Cognitive tests and serial imaging offer new Alzheimer's perspective, researchers report

07/23/2013 | MolecularImaging.net

A combination of serial F-18 FDG-PET and cognitive analyses has shed light on the progression of Alzheimer's disease. A study published in the Journal of Nuclear Medicine measured the spatial distribution of FDG over time in the brains of 51 participants divided into two groups: healthy controls and patients with mild cognitive impairment. Results showed a correlation between significant rFTC decline and longitudinal cognitive deterioration. "Such patient-based comparison is potentially less sensitive to metabolic heterogeneities across subjects and might reveal interesting links between biologic and cognitive markers of the AD state," the authors wrote of their approach.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX